Assertio Therapeutics Inc (ASRT) financials · rev $118.7M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Assertio Therapeutics Inc (ASRT) rev $118.7M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $118.7M | $125.0M |
| Operating Income | -$21.5M | -$24.5M |
| Net Income | -$30.4M | -$21.6M |
| EPS (Diluted) | -$4.74 | -$0.23 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $267.0M | $284.7M |
| Current Assets | $216.6M | $202.5M |
| Cash & Equivalents | $10.2M | $50.6M |
| Inventory | $24.1M | $38.3M |
| PP&E | $444.0K | $586.0K |
| Total Liabilities | $173.0M | $163.7M |
| Current Liabilities | $127.5M | $114.7M |
| Long-term Debt | $39.1M | $38.8M |
| Total Debt | $39.1M† | $38.8M† |
| Shareholders' Equity | $94.0M | $121.1M |
| Retained Earnings | -$703.5M | -$673.1M |
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$28.2M | $26.4M |
| CapEx | N/A | N/A |
| Investing Cash Flow | -$12.0M | -$48.9M |
| Financing Cash Flow | -$189.0K | -$350.0K |
| Net Change in Cash | -$40.4M | -$22.9M |
| Free Cash Flow | N/A | $26.4M |
FAQ
What is ASRT P/E and revenue?
Assertio Therapeutics Inc (ASRT) rev $118.7M.
What is ASRT revenue?
Assertio Therapeutics Inc last cached revenue is $118.7M (FY2025).
Is ASRT profitable?
Assertio Therapeutics Inc last cached net income is -$30.4M (FY2025).
What are ASRT total assets?
Assertio Therapeutics Inc last cached total assets are $267.0M (FY2025).
What is ASRT free cash flow?
No cached cash-flow row for ASRT yet.
Not investment advice. Cached statements, not a live tape.